Test Batch of Anti-Viral Drug Favipiravir To Hit Shelves In Russia Next Week
April 7, 2020
MOSCOW, April 7. /TASS/. The first batch of anti-viral drug Favipiravir, which showed good results when tested on novel coronavirus patients in China earlier this year, will appear on the Russian market in about one week, Russian Direct Investment Fund (RDIF) Chief Executive Officer Kirill Dmitriev said.
"Together with the ChemRar Group, we are investing into a medicine that showed excellent results in China, and the first batch will arrive in one week," he said in an interview with Russia’s Channel One on Monday night.
One America News Network: 'Hacking The Vote' Covered By Chief White House Correspondent, Chanel Rion